• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种可穿透突变型p53结肠癌细胞并结合p53的双特异性单链抗体的构建与表达。

Construction and expression of a bispecific single-chain antibody that penetrates mutant p53 colon cancer cells and binds p53.

作者信息

Weisbart Richard H, Wakelin Rika, Chan Grace, Miller Carl W, Koeffler Phillip H

机构信息

Department of Medicine, Division of Rheumatology, Veterans Affairs Greater Los Angeles Health Care System, Sepulveda, CA 91343, USA.

出版信息

Int J Oncol. 2004 Oct;25(4):1113-8.

PMID:15375563
Abstract

A bispecific, single-chain antibody Fv fragment (Bs-scFv) was constructed from a single-chain Fv fragment of mAb 3E10 that penetrates living cells and localizes in the nucleus, and a single-chain Fv fragment of a non-penetrating antibody, mAb PAb421 that binds the C-terminal of p53. PAb421 binding restores wild-type functions of some p53 mutants, including those of SW480 human colon cancer cells. The Bs-scFv penetrated SW480 cells and was cytotoxic, suggesting an ability to restore activity to mutant p53. COS-7 cells (monkey kidney cells with wild-type p53) served as a control since they are unresponsive to PAb421 due to the presence of SV40 large T antigen that inhibits binding of PAb421 to p53. Bs-scFv penetrated COS-7 cells but was not cytotoxic, thereby eliminating non-specific toxicity of Bs-scFv unrelated to binding p53. A single mutation in CDR1 of PAb421 VH eliminated binding of the Bs-scFv to p53 and abrogated cytotoxicity for SW480 cells without altering cellular penetration, further supporting the requirement of PAb421 binding to p53 for cytotoxicity. Our study demonstrates the use of an antibody that penetrates living cells in the design of a bispecific single chain antibody to target and restore the function of an intracellular protein.

摘要

一种双特异性单链抗体Fv片段(Bs-scFv)由可穿透活细胞并定位于细胞核的单克隆抗体3E10的单链Fv片段,以及与p53 C末端结合的非穿透性抗体单克隆抗体PAb421的单链Fv片段构建而成。PAb421的结合可恢复某些p53突变体的野生型功能,包括SW480人结肠癌细胞的功能。Bs-scFv可穿透SW480细胞并具有细胞毒性,表明其具有恢复突变型p53活性的能力。COS-7细胞(具有野生型p53的猴肾细胞)用作对照,因为由于存在抑制PAb421与p53结合的SV40大T抗原,它们对PAb421无反应。Bs-scFv可穿透COS-7细胞但无细胞毒性,从而消除了与结合p53无关的Bs-scFv的非特异性毒性。PAb421 VH的CDR1中的单个突变消除了Bs-scFv与p53的结合,并消除了对SW480细胞的细胞毒性,而不改变细胞穿透性,进一步支持了PAb421与p53结合对细胞毒性的必要性。我们的研究证明了在设计双特异性单链抗体以靶向和恢复细胞内蛋白质功能时使用可穿透活细胞的抗体。

相似文献

1
Construction and expression of a bispecific single-chain antibody that penetrates mutant p53 colon cancer cells and binds p53.一种可穿透突变型p53结肠癌细胞并结合p53的双特异性单链抗体的构建与表达。
Int J Oncol. 2004 Oct;25(4):1113-8.
2
Combining intracellular antibodies to restore function of mutated p53 in cancer.利用细胞内抗体恢复癌症中突变型 p53 的功能。
Int J Cancer. 2016 Jan 1;138(1):182-6. doi: 10.1002/ijc.29685. Epub 2015 Sep 3.
3
Restoration of transcriptional activity of p53 mutants in human tumour cells by intracellular expression of anti-p53 single chain Fv fragments.
Oncogene. 1999 Jan 14;18(2):551-7. doi: 10.1038/sj.onc.1202338.
4
Microinjection of monoclonal antibody PAb421 into human SW480 colorectal carcinoma cells restores the transcription activation function to mutant p53.将单克隆抗体PAb421显微注射到人SW480结肠癌细胞中可恢复突变型p53的转录激活功能。
Cancer Res. 1995 Aug 15;55(16):3490-4.
5
Single chain antibody against the common epitope of mutant p53 restores wild-type activity to mutant p53 protein.针对突变型p53共同表位的单链抗体可使突变型p53蛋白恢复野生型活性。
FEBS Lett. 2005 Oct 24;579(25):5609-15. doi: 10.1016/j.febslet.2005.09.031. Epub 2005 Sep 28.
6
Antibody-mediated p53 protein therapy prevents liver metastasis in vivo.抗体介导的p53蛋白疗法可在体内预防肝转移。
Cancer Res. 2007 Feb 15;67(4):1769-74. doi: 10.1158/0008-5472.CAN-06-3783.
7
Single-chain Fv/folate conjugates mediate efficient lysis of folate-receptor-positive tumor cells.单链Fv/叶酸缀合物介导对叶酸受体阳性肿瘤细胞的有效裂解。
Bioconjug Chem. 1997 May-Jun;8(3):338-46. doi: 10.1021/bc9700244.
8
Antibody-mediated transduction of p53 selectively kills cancer cells.抗体介导的p53转导可选择性杀死癌细胞。
Int J Oncol. 2004 Dec;25(6):1867-73.
9
[Construction and characterization of bispecific single-chain antibody fragments SZ-2/SZ-21 against platelet glycoprotein Ib alpha and beta3].抗血小板糖蛋白 Ibα 和 β3 的双特异性单链抗体片段 SZ-2/SZ-21 的构建与鉴定
Zhonghua Yi Xue Za Zhi. 2002 Nov 10;82(21):1493-7.
10
Characterization of scFv-421, a single-chain antibody targeted to p53.
Biochem Biophys Res Commun. 1997 Jan 13;230(2):242-6. doi: 10.1006/bbrc.1996.5930.

引用本文的文献

1
Cellular protection from HO toxicity by Fv-Hsp70: protection via catalase and gamma-glutamyl-cysteine synthase.Fv-Hsp70 对 HO 毒性的细胞保护作用:通过过氧化氢酶和γ-谷氨酰半胱氨酸合成酶实现保护。
Cell Stress Chaperones. 2023 Jul;28(4):429-439. doi: 10.1007/s12192-023-01349-6. Epub 2023 May 12.
2
Antibody-Based Approaches to Target Pancreatic Tumours.基于抗体的胰腺肿瘤靶向治疗方法。
Antibodies (Basel). 2022 Jul 12;11(3):47. doi: 10.3390/antib11030047.
3
Bispecific Antibodies Progression in Malignant Melanoma.双特异性抗体在恶性黑色素瘤中的进展
Front Pharmacol. 2022 Mar 23;13:837889. doi: 10.3389/fphar.2022.837889. eCollection 2022.
4
Targeted Intracellular Delivery of Antibodies: The State of the Art.抗体的靶向细胞内递送:现状
Front Pharmacol. 2018 Oct 24;9:1208. doi: 10.3389/fphar.2018.01208. eCollection 2018.
5
mRNA as novel technology for passive immunotherapy.mRNA 作为一种新型的被动免疫治疗技术。
Cell Mol Life Sci. 2019 Jan;76(2):301-328. doi: 10.1007/s00018-018-2935-4. Epub 2018 Oct 17.
6
Emerging Non-Canonical Functions and Regulation by p53: p53 and Stemness.p53的新兴非经典功能与调控:p53与干性
Int J Mol Sci. 2016 Nov 26;17(12):1982. doi: 10.3390/ijms17121982.
7
A tale of two specificities: bispecific antibodies for therapeutic and diagnostic applications.双特异性抗体:治疗和诊断应用的两种特异性。
Trends Biotechnol. 2013 Nov;31(11):621-32. doi: 10.1016/j.tibtech.2013.08.007. Epub 2013 Oct 2.
8
Recombinant Fv-Hsp70 protein mediates neuroprotection after focal cerebral ischemia in rats.重组 Fv-Hsp70 蛋白在大鼠局灶性脑缺血后介导神经保护作用。
Stroke. 2010 Mar;41(3):538-43. doi: 10.1161/STROKEAHA.109.572537. Epub 2010 Jan 14.